Helene Lindfors, Ph.D. Student at the Endocrine Surgery research group, the Department of Molecular Medicine and Surgery, ...

Tumor-marker monitoring is potentially a powerful tool to accomplish these goals. For follicular cell-derived thyroid carcinoma (excluding anaplastic cancer), which accounts for approximately 97% ...

Thyroid cancer is a type of cancer that starts in your thyroid gland. A gland is an organ in your body that makes a substance. Your thyroid is shaped like a small butterfly and is found inside the ...

Papillary thyroid carcinoma is the most common type of cancer to affect your thyroid-- a butterfly-shaped gland that sits just below your voice box. It's only about as big as a quarter ...

Papillary and follicular thyroid cancers are considered well-differentiated cancers. Papillary thyroid cancer is the most prevalent type of thyroid cancer--with over 50,000 new cases per year in the ...

New research indicates GLP1-RA medications do not increase thyroid cancer risk, reassuring users and clinicians. A new study, ...

Tumor-specific thyroid cancer markers (e.g., tumor-specific mutations) are also likely to become increasingly important for follow-up of patients with residual glands. Example of a precision ...

Head and neck, surgical, radiation, and medical oncologists in the Baylor St. Luke's Medical Center Dan L Duncan Comprehensive Cancer Center specialize in the diagnosis and treatment of thyroid cancer ...